Insights
Search Results
Client Highlights
4.17.26
Firm Advises Neurona Therapeutics on Acquisition by UCB
On April 17, 2026, UCB, a global biopharmaceutical company, announced that it has entered into a definitive agreement under which UCB would acquire Neurona Therapeutics, including lead asset NRTX-1001, adding to UCB’s epilepsy portfolio. Neurona Therapeutics is a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for epilepsies and other disorders of the nervous system. Under the terms of the agreement, UCB will pay $650 million upfront and up to $500 million in potential future milestone payments, subject to certain closing conditions. Wilson Sonsini Goodrich & Rosati advised Neurona on the transaction.
Client Highlights
11.17.25
Wilson Sonsini Advises onX on Strategic Investment from TCV
On November 3, 2025, onX, a pioneer in digital outdoor navigation and mapping software, announced a strategic investment from TCV, a leading growth equity firm known for supporting enduring consumer technology brands. The partnership brings additional operational expertise and long-term support as onX continues to scale its suite of adventure-specific navigation apps and redefine the outdoor experience. The company's existing investors, including Summit Partners, Madison Valley Partners, and onX founder Eric Siegfried, will remain active board members. Wilson Sonsini Goodrich & Rosati advised onX on the transaction.
Client Highlights
10.13.25
Wilson Sonsini Advises Fivetran on Merger with dbt Labs
On October 13, 2025, Fivetran, a global leader in automated data movement, announced that it signed a definitive agreement to merge with dbt Labs, a pioneer of modern data transformation, in an all-stock deal. The combined company will be approaching $600 million in annual recurring revenue. The transaction marks significant consolidation in the data tooling market as enterprises race to adapt infrastructure for artificial intelligence applications. Wilson Sonsini Goodrich & Rosati advised Fivetran on the transaction.
Client Highlights
8.28.25
Wilson Sonsini Advises Uniphore on Orby AI and Autonom8 Transactions
On August 28, 2025, Uniphore, the Business AI company, announced that it has acquired Orby AI, Inc. and intends to acquire Autonom8, Inc., two AI-native companies that will enhance the capabilities of Uniphore’s Business AI Cloud. Both teams bring top AI research and engineering talent from DeepMind and Google, adding unmatched expertise and proven innovation to push the boundaries of Business AI. Wilson Sonsini Goodrich & Rosati advised Uniphore on both transactions.
Client Highlights
8.01.25
Wilson Sonsini Advises Scale Computing on Acquisition by Acumera
On July 31, 2025, Acumera, a leading provider of secure edge connectivity, visibility, and computing solutions, announced its acquisition of Scale Computing, a pioneer in hyperconverged infrastructure and edge virtualization. The combined company will be known as Scale Computing and will serve as the largest edge computing-focused software company in the industry, with the ability to serve customers worldwide. Wilson Sonsini Goodrich & Rosati advised Scale Computing on the transaction.
Client Highlights
6.27.25
Wilson Sonsini Advises Xero on Acquisition of Melio for up to $3 Billion
On June 24, 2025, New Zealand-based Xero Limited, a global small business platform that helps customers supercharge their business by bringing together the most important small business tools, announced it has entered into an agreement to acquire U.S.-based Melio Limited, a leading SMB bill pay platform that seamlessly integrates accounting and payments, and its associated entities (collectively Melio). The acquisition is expected to be funded through a mix of cash and equity, with an upfront consideration of $2.5 billion in cash and equity consideration and up to $500 million in contingent consideration, deferrals and rollovers payable to Melio employees. Wilson Sonsini Goodrich & Rosati is serving as lead counsel to Xero on the acquisition.
Client Highlights
4.09.25
Wilson Sonsini Advises Marvell on Infineon's $2.5 Billion Acquisition of Automotive Ethernet Business
On April 8, 2025, Marvell Technology, a leader in data infrastructure semiconductor solutions, announced that it has entered into a definitive agreement under which Infineon Technologies will acquire Marvell's Automotive Ethernet business in an all-cash transaction valued at $2.5 billion. Wilson Sonsini Goodrich & Rosati advised Marvell on the transaction.
Client Highlights
12.20.24
Wilson Sonsini Advises Aadi Bioscience on $100 Million Sale of FYARRO®, $100 Million PIPE Financing and License Agreement for ADC Portfolio
On December 19, 2024, Aadi Bioscience announced that it had entered into an agreement to sell its commercial drug product FYARRO® to KAKEN Pharmaceutical for $100 million, an agreement to sell and issue $100 million of equity in a PIPE financing, and an exclusive license agreement for the development and global commercialization of a three-asset portfolio of preclinical, next-wave antibody-drug conjugates (ADCs), in collaboration with WuXi Biologics, a global Contract Research, Development and Manufacturing Organization, and Hangzhou DAC, a global leader in ADC innovation.